Business
CVD, Dymax & Keyence Collaborate to Accelerate ECMO Development
CENTRAL ISLIP, N.Y.--(BUSINESS WIRE)-- CVD Equipment Corporation (NASDAQ: CVV) today announced that its subsidiary, CVD Materials Corporation (CVDM), will
About this update from Cvd Equipment Corporation
[{"type":"text","content":" CENTRAL ISLIP, N.Y.--(BUSINESS WIRE)--\nCVD Equipment Corporation (NASDAQ: CVV) today announced that its subsidiary, CVD Materials Corporation (CVDM), will together with Dymax Corporation and Keyence Corporation of America collaborate in an effort to accelerate the development of CVDM’s novel c-VACNT™ Extracorporeal Membrane Oxygenation (ECMO) platform. ECMO devices are used to add Oxygen and remove Carbon Dioxide from a blood stream during periods when the patient’s lungs are not performing at appropriate levels. Typically, they are used during heart / lung surgery, but have recently been used as a last resort for recovery from COVID-19 illness.\n\n\nCVDM will incorporate Dymax’s UV curing materials and Keyence’s 2D scanning technology for manufacturing ECMO prototype test devices based on CVDM’s patent pending c-VACNT™ materials platform. This multi company collaboration is intended to facilitate manufacturing for a range of novel ECMO devices for in-vitro and in-vivo tests to document their efficiency and safety.\n\n\n“We believe this multi company collaborative effort will in the next several months result in CVDM providing our c-VACNT™ based prototype ECMO devices to leading ECMO companies for their internal testing and performance evaluation,” said Leonard Rosenbaum, President and CEO of CVD Equipment Corporation.\n\n\nDymax: “Our 1405M-T-UR-SC UV curable adhesive that was provided to CVDM is already used in current ECMO device manufacturing. We anticipate the glue will be successful during in-vitro and in-vivo evaluation.”\n\n\nKeyence: “Our latest release in precision laser measurement technology, is the LJ-X8000 series Laser Profiler. The system was provided to CVDM to help accelerate manufacturing, improve the yield, and to inspect final c-VACNT™ ECMO units. ECMO manufacturing is another application in the medical field where our 2D/3D scanning technology shows promise.”\n\n\nAbout Dymax Corporation\nDymax Corporation develops innovative rapid and light-curable materials, dispensing equipment, and UV/LED light-curing systems. The company’s adhesives, coatings, and equipment are matched to work seamlessly with each other, providing design engineers with tools to improve manufacturing efficiencies. Major markets include aerospace and defense; medical devices; consumer and automotive electronics.\n\n\nFor additional info...